Köpenysejtes limfóma: vizsgálatok itt: Kanada
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Where
- London, Ottawa, Toronto
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06084936 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Montreal, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 1. fázisTaking peopleIKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659 - 1. fázisTaking peopleCLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- Where
- Calgary, Ottawa, Toronto, Vancouver
- Életkor
- 1 év and over
- People
- 24
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT06208735 - 2. fázisTaking peopleSonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
- Where
- Calgary, Edmonton, Hamilton, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 40
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT07341191 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Calgary, Edmonton, Québec, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - No phaseTaking peoplePreliminary Assessment of [18F]BL40 in PET/CT Scans
- Where
- Vancouver
- Életkor
- 19 év to 100 év
- People
- 30
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT06224309 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Calgary, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 2. fázisTaking peopleDALY II USA/ MB-CART2019.1 for DLBCL
- Where
- Edmonton, Toronto
- Életkor
- 18 év and over
- People
- 315 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04792489 · EU 2023-508508-39-01